Botanical species · safety record
Gossypium herbaceum
The EFSA Compendium of Botanicals holds 2 constituent measurements and 2 adverse-effect records for Gossypium herbaceum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Gossypium herbaceum L.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 14 licensed products naming Gossypium herbaceum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Source material stated
What the records describe
Constituents measured
- Free gossypol2
Plant parts
- Seed3
Preparations
- Solvent extraction2
Effect types
- Developmental1
- Systemic1
Target tissues
- Cardiovascular1
- Uterus1
- haematological1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Free gossypol | Seed | Solvent extraction | ≤ 71 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | No resolvable identifier |
| Free gossypol | Seed | Solvent extraction | ≥ 59.3 Percent | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Developmental | Uterus | Seed | — | Rat (as animal) | Reproduction toxicity | No resolvable identifier |
| Systemic | Cardiovascular / haematological | — | — | Rat (as animal) | Short-term toxicity | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Mello, Joao R. B., Mello, Fernanda B., Etges, Rodrigo N., Hollenbach, Clarissa., Rodrigues, Juliano M., Hirtz, Lucas. Pre-clinic toxicity of a phytotherapic containing Gossypium herbaceum (cotton plant) in Wistar rats . Latin american journal of pharmacy, 2008, vol. 27, no. 1, p. 46-55.
- Nath, D., Sethi, N., Srivastava, S., Jain, A. K., Srivastava, R. Teratogenic evaluation of an indigenous antifertility medicinal plant Gossypium herbaceum in rat . Fitoterapia, 1997, vol. 68, no. 2, p. 137-139.
- Stipanovic, Robert D., Puckhaber, Lorraine S., Bell, Alois A., Percival, Albert E., Jacobs, John. Occurrence of (+)- and (-)-Gossypol in Wild Species of Cotton and in Gossypium hirsutum Var. marie-galante (Watt) Hutchinson. Journal of agricultural and food chemistry, 2005, vol. 53, no. 16, p. 6266-6271.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.